Article
Charge alterations of E22 enhance the pathogenic properties of the amyloid beta-protein.
Journal of neurochemistry - 1 May 2000
Melchor J P, McVoy L, Van Nostrand W E
Abstract excerpt
Cerebral amyloid angiopathy (CAA) due to amyloid beta-protein (Abeta) is a key pathological feature of patients with Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D). The CAA in these disorders is characterized by deposition of Abeta in the smooth muscle cells within the cerebral vessel wall. Recently, a new mutation in Abeta, E22K, was identified in several Italian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
